+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lycera Corp - logo

Lycera is a biopharmaceutical company that is developing novel small molecule immunomodulatory medicines for the treatment of autoimmune diseases and cancer. The company offers novel oral medicines for diseases such as rheumatoid arthritis, multiple sclerosis, psoriasis, and inflammatory bowel disease. Its lead product is LYC-30937, an ATPase modulator for the treatment of inflammatory bowel disease. Lycera was founded in 2006 and is headquartered in Ann Arbor, Michigan.

Psoriasis - Pipeline Review, H2 2019 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2019

  • Drug Pipelines
  • 803 Pages
From
From
From
From
Bladder Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Bladder Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 999 Pages
From
From
Ovarian Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2412 Pages
From
From
From
Bladder Cancer - Pipeline Review, H2 2017 - Product Thumbnail Image

Bladder Cancer - Pipeline Review, H2 2017

  • Drug Pipelines
  • 937 Pages
From
Fibrosis - Pipeline Review, H1 2017 - Product Thumbnail Image

Fibrosis - Pipeline Review, H1 2017

  • Drug Pipelines
  • 132 Pages
From
  • 19 Results (Page 1 of 1)
Loading Indicator
adroll